Hampton Creek Press (print and distribution provided by Simon & Schuster) Announces Behind a Closed Door, the Latest Novel by Writer J.D. Barker
17 avr. 2024 13h51 HE
|
Hampton Creek Press
The long-awaited thriller from New York Times bestselling author J.D. Barker is available for preorder now and will be released on May 13, 2024.
Yamaha Outdoor Access Initiative Sponsors Recreation Exhibit at New National Conservation Legacy Center in Missoula, Montana
17 avr. 2024 12h00 HE
|
Yamaha Motor Corp., USA
MARIETTA, Ga., April 17, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, today announces it will be the exclusive motorized recreation sponsor of the Recreation exhibit at the National...
OMNIQ ANNOUNCES 2023 REVENUE OF $81.4 MILLION
01 avr. 2024 17h11 HE
|
OMNIQ Corp.
SALT LAKE CITY, April 01, 2024 (GLOBE NEWSWIRE) -- OMNIQ Corp. (NASDAQ: OMQS) (“OMNIQ” or the “Company”), a provider of Artificial Intelligence (AI) and IoT–based solutions will release Full Year...
aTyr Pharma to Participate in April Investor Conferences
01 avr. 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma to Participate in April Investor Conferences
Moxies announces the renovation of its celebrated Dallas Crescent location
01 mars 2024 06h00 HE
|
Moxies
DALLAS, March 01, 2024 (GLOBE NEWSWIRE) -- Situated in the heart of Uptown Dallas, Moxies is delighted to announce a refresh of its popular location at 100 Crescent Court, Ste 140. Already renowned...
[Latest] Global Banking Cyber Security Market Size/Share Worth USD 285.4 Billion by 2032 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
23 févr. 2024 02h30 HE
|
Custom Market Insights
Austin, TX, USA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Banking Cyber Security Market Size, Trends and Insights By Type (Cloud Security,...
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
29 janv. 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023
13 nov. 2023 08h00 HE
|
aTyr Pharma, Inc.
SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its...
aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
09 nov. 2023 16h00 HE
|
aTyr Pharma, Inc.
Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT™ study of efzofitimod in SSc-ILD initiated...
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
11 sept. 2023 08h00 HE
|
aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...